Hypersensitivity
CLBT 1050: SEROLOGY
HYPERSENSITIVITY
Definition
- Hypersensitivity:
- An exaggerated immune response to a typically harmless antigen.
- Results in injury to tissue, disease, or even death.
Malfunctions of Immune System
- Hypersensitivity types:
- Type I
- Type II
- Type III
- Type IV
- Other Related Conditions:
- Autoimmunity
- Immunodeficiency
Types of Hypersensitivity
- Delayed Reactions:
- Develop 24 to 48 hours after antigen exposure (Type IV)
- Immediate Reactions:
- Develop minutes to hours after exposure (Type I, Type II, Type III)
TYPE I HYPERSENSITIVITY
- Characteristics:
- Also known as anaphylactic hypersensitivity.
- Typically thought of as “allergies.”
- Key Components:
- IgE
- Mast cells
- Basophils
- Eosinophils
- Key Reactant: IgE antibody
Sensitization Phase
- Process:
- Antigen-presenting cells (APCs) process allergens and present them to T-helper cells.
- T-helper 2 cells induce production of allergen-specific IgE.
- IgE binds to FcεRI receptors on mast cells and basophils.
Activation Phase
- Process:
- Allergen cross-links adjacent cell-bound IgE’s.
- Mast cells and basophils degranulate.
- Chemical mediators are released and bind to target organs.
- Allergy symptoms are produced.
Anaphylaxis
- Definition:
- Most severe type of allergic response.
- Acute response involving multiple organs.
- Can be fatal if not treated immediately.
- Symptoms begin within minutes and may include:
- Bronchospasm
- Laryngeal edema
- Vascular congestion
- Skin manifestations
- Diarrhea
- Vomiting
- Intractable shock
- Death may result from asphyxiation due to airway edema and congestion.
- Example of edema: Swelling of feet and ankles, edema of airways.
Common Allergens
- Pollen
- Mold spores
- Animal dander
- Dust mites
- Insect venom
- Certain Foods (e.g., peanuts, shellfish, dairy products)
- Certain Drugs (e.g., penicillin)
- Latex
Clinical Manifestations of Type I Hypersensitivity
- Rhinitis (“hay fever”)
- Allergic asthma
- Food allergies
- Urticaria (“hives”)
- Eczema
- Systemic anaphylaxis (a potentially fatal reaction)
Treatments for Type I Hypersensitivity
- Avoidance of allergens.
- Drug therapy:
- Antihistamines
- Bronchodilators
- Mast cell stabilizers
- Corticosteroids
- Epinephrine
- Allergy immunotherapy (AIT):
- Monoclonal anti-IgE antibody administration, usually starting with gradual increases of allergen.
Testing for Type I Hypersensitivity
- In vivo Testing:
- Skin prick test: Apply allergens to skin and wait 15-20 minutes to check for reaction.
- In vitro Testing:
- RIST (RadioImmunoSorbant Test): Measures total IgE
- RAST (Radio Allergen Specific Test): Assesses allergen-specific IgE, using radio-labeled anti-human IgE to bind with antibodies already present in serum.
TYPE II HYPERSENSITIVITY
Characteristics
- Definition:
- Occurs against normal self-antigens due to failure of immune tolerance.
- Involves IgM & IgG antibodies directed against a cell surface antigen, also known as antibody-mediated cytotoxic hypersensitivity.
Mechanism
- Mechanisms of damage:
- Antibody binds to antigen leading to:
- Phagocytosis of opsonized cells by neutrophils and macrophages.
- Activation of NK (Natural Killer) cells.
- Induction of inflammation through interactions with WBC Fc receptors and complement pathway breakdown.
- Complement-mediated lysis causes cell destruction.
- Antireceptor antibodies may disturb normal cellular function (e.g., anti-TSH receptors, anti-Acetylcholine receptor antibodies).
Clinical Examples of Type II Hypersensitivity
- Transfusion reactions
- Hemolytic disease of the newborn (HDN)
- Autoimmune hemolytic anemia
- Other examples: Warm reactive antibodies, cold agglutinins, paroxysmal cold hemoglobinuria, Anti-GBM disease (Goodpasture’s syndrome), Hashimoto’s disease.
Hemolytic Disease of the Newborn (HDN)
- Occurs when a pregnant woman produces antibodies against Rh antigens on fetal RBCs (usually RhD).
Diagnostic Tests for Type II Hypersensitivity
- Direct Antiglobulin Test (DAT):
- Detects RBCs coated with complement components or IgG antibody.
- Method: Patient RBCs are incubated with a poly-specific anti-human Ig, directed against IgG and complement. Positive agglutination indicates a reaction.
- Indirect Antiglobulin Test (Coombs’ test):
- Tests patient serum for antibodies to RBC antigens.
- Process: Incubate reagent RBCs with patient serum at 37°C, wash off excess, and add anti-human globulin. Positive test = RBC agglutination.
TYPE III HYPERSENSITIVITY
Characteristics
- Definition:
- Also known as immune complex-mediated hypersensitivity.
- Involves antigen-antibody complexes directed against soluble antigens.
- Complexes deposit in organs and tissues, causing damage.
- Cells such as macrophages and neutrophils migrate to the affected areas, releasing lysosomal enzymes resulting in tissue damage.
Mechanism of Tissue Damage
- Immune complexes (IgG and IgM) precipitate out of serum and deposit in tissues.
- Tissue damage arises from complement activation and inflammatory responses resulting from antibody binding to cellular receptors.
Clinical Examples of Type III Hypersensitivity
- Arthus Reaction:
- Skin reaction characterized by localized inflammation (redness and edema) that peaks at 3 to 8 hours.
- Known as Farmer’s Lung or Pigeon Breeder’s Lung.
- Serum Sickness:
- A generalized type III hypersensitivity caused by passive immunization with animal serum, producing antibodies against foreign animal proteins.
- Symptoms include headache, fever, nausea, joint pain, rashes, and lymphadenopathy.
- Associations with other conditions:
- Autoimmune diseases (e.g., systemic lupus erythematosus, rheumatoid arthritis).
- Reactions to bee stings.
- Drug reactions (e.g., penicillin).
- Sequelae to infections (e.g., post-streptococcal glomerulonephritis).
TYPE IV HYPERSENSITIVITY
Characteristics
- Definition:
- Also known as delayed type hypersensitivity (DTH) and is cell-mediated.
- Key players: Th1 cells and macrophages.
- Antigen-presenting cells (APCs) present antigens to naïve T helper cells which differentiate into Th1 cells release cytokines that attract macrophages, inducing inflammation and recruiting cytotoxic T lymphocytes to destroy target cells.
- Hypersensitivity reaction peaks 48 to 72 hours after antigen exposure.
Clinical Examples of Type IV Hypersensitivity
- Infections with intracellular pathogens (e.g., Mycobacterium tuberculosis, Mycobacterium leprae, Pneumocystis carinii, Leishmania species, herpes simplex virus).
- Contact dermatitis caused by low-molecular-weight compounds that act as haptens (examples: poison ivy, nickel salts).
- Allergic diseases of the lungs from inhalation of bacterial and fungal spores (e.g., Farmer’s lung disease, bird breeder’s lung disease).
Skin Testing for Delayed Hypersensitivity
- Methods:
- Inject common antigens intradermally (patch test for contact dermatitis). (+) test shows redness with papules or blisters.
- Mantoux Method:
- Injects PPD intradermally. (+) test indicates induration suggesting TB infection.
Interferon Gamma Release Assays (IGRA)
- Measure the production of IFN-γ by T cells stimulated with MTB antigens.
- Quantiferon TB Gold Plus assay: Incubates patient blood in tubes with MTB antigens and tests the plasma for IFN-γ by ELISA.
- T-SPOT-TB test: Mononuclear cells incubated with MTB antigens tested for IFN-γ with ELISpot.
Summary of Hypersensitivity Reactions
- Type I: Immediate reactions involving the release of mediators from IgE-sensitized mast cells and basophils after cross-linking by allergens.
- Type II: Cell destruction is caused by antibody and complement leading to opsonization; inhibition of cell functions may also occur.
- Type III: Antigen-antibody complexes activate complement, leading to neutrophil recruitment and tissue damage.
- Type IV: Antigen-sensitized Th1 cells release cytokines that recruit macrophages and induce inflammation, activating cytotoxic T cells that cause direct cell damage.
Types of Allergy Reactions
| Type | Mechanism | Main Characteristics | Examples |
|---|---|---|---|
| Type I | Specific IgE | Immediate reactions; classical allergies. | Allergic Anaphylaxis and Atopy |
| Type II | Antibody-mediated | Cell surface antigen specifically reacting with antibodies. | Hemolytic anemia, penicillin sensitivity. |
| Type III | Immune complex-mediated | Deposited soluble immunocomplexes. | Serum sickness, SLE |
| Type IV | T cell-mediated | Cytokines and cytotoxicity from sensitized T cells. | Contact dermatitis |
Note: Hypersensitivity reactions may appear alongside autoimmune diseases.